Boerhinger Ingelheim’s Phase II Agent Could Be The First Second-Wave Protease Inhibitor For Hep C (Health News Daily)
Panel Rejects Zimmer’s Dynesys Spine Stabilization Device PMA, Faults Data(Health News Daily)
Merged House Bill Seeks More Part D Savings, Broader Medicaid Expansion(The Pink Sheet)
This is copyright protected information, to receive the full article, please click here to sign up and register.
A Lead Drug on the Way? All Eyes on FDA (PharmExec Direct)
Larger Merck says merger will actually increase R&D efficiency (PharmTimes)
EU drugmakers agree breakthrough on patient information (PharmaTimes)
Biovitrum to buy Swedish Orphan in $494 million deal (PharmaTimes)
Pfizer’s Chantix helps COPD patients quit smoking – study (PharmaTimes)
Panel Rejects Zimmer’s Dynesys Spine Stabilization Device PMA, Faults Data (Health News Daily)
SUBSCRIBE